Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling.
Published:1 April 2024
DOI: 10.1016/j.celrep.2024.114075
Dandan Zhong, Jingshuo Chen, Ranran Qiao, Chang Song, Chang Hao, Yingying Zou, M. Bai, Wen Su, Baoxue Yang, Dong Sun, Zhanjun Jia, Ying Sun
Abstract




